24-HOUR SYMPTOM RELIEF

IN PATIENTS WITH EE1-3

In patients with erosive esophagitis (EE), treatment with NEXIUM provided 24-hour symptom relief1–3

85% to 91% heartburn-free nights

  • The percent of heartburn-free nights with NEXIUM 40 mg at week 4 ranged from 85% to 91%, based on patient diaries from 3 studies1–3,a
  • With NEXIUM 20 mg, the percent of heartburn-free nights at week 4 ranged from 84% to 86%, based on patient diaries from 2 studies2,4,a

73% to 75% heartburn-free days

  • The percent of heartburn-free days with NEXIUM 40 mg at week 4 ranged from 73% to 75%, based on patient diaries from 3 studies1–3,a
  • With NEXIUM 20 mg, the percent of heartburn-free days at week 4 ranged from 69% to 73%, based on patient diaries from 2 studies2,4,a

View healing data for NEXIUM vs omeprazole and lansoprazole

aSecondary endpoints from 4 multicenter, randomized, double-blind trials comparing oral doses of NEXIUM vs omeprazole, administered once daily to patients with endoscopically diagnosed EE. Primary endpoint was healing of EE at week 8 (N=2425),1 (N=1960),2 (N=1148),3 (N=1175).4

NEXIUM 20 mg is the FDA-approved dose for the symptom relief of gastroesophageal reflux disease (GERD).

NEXIUM 40 mg and NEXIUM 20 mg are the FDA-approved doses for the healing of EE. There is no correlation between symptom relief and the healing of EE with NEXIUM.